Cyclobenzaprine Hydrochloride Tablet, Film Coated
Product Images NDC 50268-190

2 FDA label images from Avpak · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 50268-190). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avpak, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Flexeril (cyclobenzaprine HCl) Structural Formula Illustration (8b931a82 Figure 01)

Flexeril (cyclobenzaprine HCl) Structural Formula Illustration (8b931a82 Figure 01)
Chemical structure of Cyclobenzaprine Hydrochloride, showing its molecular framework with aromatic rings and functional groups.*
FDA Label Image

Label 5026819015 Cyclobenzaprine Hci 5mg

Label 5026819015 Cyclobenzaprine Hci 5mg
Label for Cyclobenzaprine Hydrochloride Tablets, USP 5 mg by AvPAK, showing the NDC 50268-190-15. The label indicates the product contains 50 film-coated tablets in unit dose packaging, intended for Rx only. Storage instructions and manufacturer details for AvKARE, Inc., Pulaski, TN, are also shown.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.